Portfolio company
Axiom Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops artificial intelligence models that predict drug toxicity to help pharmaceutical researchers identify safety risks early in the development process.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Toxometris.ai
This company provides an artificial intelligence platform for predicting chemical toxicity and drug properties for pharmaceutical and biotechnology researchers.
Anto Biosciences
This company develops foundation models for microbial communities to predict drug toxicity and efficacy for pharmaceutical and biotechnology researchers.
Anto
This company develops foundation models to predict drug toxicity and efficacy by analysing gut microbiome data for pharmaceutical firms and drug developers.
Drug Discovery
This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.
Atlas Bio
This company develops deep learning software for pharmaceutical firms to predict molecular interactions and simulate animal testing during drug development.
Ingenix
This company develops an artificial intelligence system that integrates biological data to support drug development decisions for pharmaceutical and biotechnology organisations.
DreamFold
This company develops generative AI models for protein design to discover new therapeutic drugs for pharmaceutical researchers and clinicians.
Khumbu
This company develops artificial intelligence models for molecular biology and protein-ligand interactions to accelerate drug discovery for the pharmaceutical industry.
